1
/
of
0
FDA Summary Basis of Approval – Fluticasone Propionate Nasal Spray, 50mcg/Spray (ANDA 76504 & 207957, HIKMA PHARMACEUTICALS USA INC)
FDA Summary Basis of Approval – Fluticasone Propionate Nasal Spray, 50mcg/Spray (ANDA 76504 & 207957, HIKMA PHARMACEUTICALS USA INC)
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request Contents: Request Summary Basis of Approval for Fluticasone Propionate Nasal Spray, 50mcg/Spray for ANDA 76504 and ANDA 207957 (HIKMA PHARMACEUTICALS USA INC)
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details